The high cost of diagnosing and treating cancer—in addition to the prescription drugs and therapies associated with the disease—is bankrupting hard-working Americans, who cannot afford…
Read More
Cancer diagnosis and treatment need to be improved—and theranostics technology is working to bring a solution to market. NuView Life Sciences is focused on a…
PARK CITY, Utah (PRWEB)August 03, 2020 NuView Life Sciences, Inc. announced that it has signed an agreement with GEM Global Yield LLC SCS, a Luxembourg-based…
PARK CITY, Utah, August 13, 2019 /PRNewswire-PRWeb/ — The American Society of Breast Surgeons recently announced new cancer screening guidelines that are designed to help…
A recent study validating urine diagnosis for cancer cell receptors in prostate cancer is eclipsing traditional methodology and warrants further steps toward FDA approval says…
The cancer (tumor) profiling market is expected to grow at a CAGR of 19.1% over the next four years. This growth directly reflects the public’s…
Cancer diagnostics technology continues to evolve, with emerging science based in precision medicine beginning to dominate the industry. Even though global markets are primarily focused…
As cancer rates continue to rise, patients increasingly bear the brunt of both the financial and emotional costs related to their diagnosis. In an effort…
While genetic testing has been used for years to diagnose cancer, it is now finding new application in the identification of cancerous mutations that will…
False positive cancer screening tests often lead to unnecessary and invasive biopsies that can emotionally, physically and financially devastate patients. To help move the focus…
